all report title image
  • Published In : Mar 2024
  • Code : CMI6791
  • Pages : 165
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Global type 1 diabetes market is estimated to be valued at USD 15.95 BN in 2024 and is expected to exhibit a CAGR of 6.2% during the forecast period (2024-2031). Type 1 diabetes is an autoimmune disease where the pancreas produces little or no insulin. It results from the destruction of insulin-producing beta cells in the pancreas. Insulin is a hormone that regulates blood sugar. Without insulin, glucose stays in the blood and cannot be used for energy. As a result, blood glucose (sugar) levels become high. Symptoms of type 1 diabetes include increased thirst, increased urination, weight loss despite increased appetite, blurred vision and tiredness. While there is no cure for type 1 diabetes, it can be managed through insulin therapy, diet, exercise, and self-monitoring of blood glucose levels. Global type 1 diabetes market consists of devices and therapeutics used for monitoring and managing blood glucose levels in type 1 diabetes patients.

Market Dynamics:

Global type 1 diabetes market growth is primarily driven by rising prevalence of type 1 diabetes across the world. According to Centers for Disease Control and Prevention press release published in November 2023, 1.7 million adults in 2021, aged 20 years or above which totals to 5.7% of all US adults with diagnosed diabetes reported that they have type 1 diabetes and use insulin. Increasing awareness regarding diabetes management and advanced monitoring devices are driving the market growth. However, high cost of insulin and other management therapies pose a major challenge to market growth. The improvements in continuous glucose monitoring devices enabled by new technologies provide lucrative opportunities for sustained market expansion.

Key Features of the Study:

  • This report provides in-depth analysis of the global type 1 diabetes market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global type 1 diabetes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study includes Biocon Ltd., Novo Nordisk, Gan & Lee Pharmaceuticals, Zealand Pharma, AstraZeneca, Eli Lilly and Company, Sanofi, Wockhardt Ltd., Ypsomed AG, Novartis, Panbela Therapeutics, Diamyd Medical, Adocia, Anelixis Therapeutics, and Oramed Pharmaceuticals Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global type 1 diabetes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global type 1 diabetes market

Detailed Segmentation-

  • By Device Type:
    • Insulin Pen
    • Insulin Syringe
    • Insulin Pump
    • Insulin Jet Injectors
  • By Insulin Type:
    • Long-Acting Insulin
    • Rapid-Acting Insulin
  • By End User:
    • Homecare Settings
    • Hospitals & Clinics
    • Academic & Research Institutes
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Biocon Ltd.
    • Novo Nordisk
    • Gan & Lee Pharmaceuticals
    • Zealand Pharma
    • AstraZeneca
    • Eli Lilly and Company
    • Sanofi
    • Wockhardt Ltd.
    • Ypsomed AG
    • Novartis
    • Panbela Therapeutics
    • Diamyd Medical
    • Adocia
    • Anelixis Therapeutics
    • Oramed Pharmaceuticals Inc.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Device Type
      • Market Snapshot, By Insulin Type
      • Market Snapshot, By End User
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Technology Overview
    • Regulatory Scenario
    • Pricing Analysis
    • PEST Analysis
  4. Global Type 1 Diabetes Market- Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the market
  5. Global Type 1 Diabetes Market, By Device Type, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Insulin Pen
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Insulin Syringe
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Insulin Pump
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Insulin Jet Injectors
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  6. Global Type 1 Diabetes Market, By Insulin Type, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Long-Acting Insulin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Rapid-Acting Insulin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  7. Global Type 1 Diabetes Market, By End User, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Homecare Settings
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Hospitals & Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Academic & Research Institutes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  8. Global Type 1 Diabetes Market, By Distribution Channel, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  9. Global Type 1 Diabetes Market, By Region, 2019 – 2031, (USD BN)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Regions, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Insulin Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Insulin Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Insulin Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Insulin Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Insulin Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Insulin Type, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Company Profiles
      • Biocon Ltd.*
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novo Nordisk
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Gan & Lee Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Zealand Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AstraZeneca
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Wockhardt Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ypsomed AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Panbela Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Diamyd Medical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Adocia
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Anelixis Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Oramed Pharmaceuticals Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  11. Analyst View
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 48 figures on "Global Type 1 Diabetes Market” – Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo